AU 461
Latest Information Update: 18 Apr 2002
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Antiulcers
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Peptic ulcer
Most Recent Events
- 18 Apr 2002 No development reported - Preclinical for Peptic ulcer in South Korea (unspecified route)
- 10 Oct 2000 New profile
- 10 Oct 2000 Preclinical development for Peptic ulcer in South Korea (Unknown route)